926 related articles for article (PubMed ID: 14669293)
21. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
[TBL] [Abstract][Full Text] [Related]
22. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
23. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
[TBL] [Abstract][Full Text] [Related]
24. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments.
Hernández-Machin B; Borrego L; Gil-García M; Hernández BH
Int J Dermatol; 2007 May; 46(5):453-9. PubMed ID: 17472670
[TBL] [Abstract][Full Text] [Related]
25. Recurrent basal cell carcinoma treated with radiation therapy.
Wilder RB; Shimm DS; Kittelson JM; Rogoff EE; Cassady JR
Arch Dermatol; 1991 Nov; 127(11):1668-72. PubMed ID: 1952970
[TBL] [Abstract][Full Text] [Related]
26. Retrospective analysis of local control and cosmetic outcome of 147 periorificial carcinomas of the face treated with low-dose rate interstitial brachytherapy.
Ducassou A; David I; Filleron T; Rives M; Bonnet J; Delannes M
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):726-31. PubMed ID: 21435798
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.
Mateoiu C; Pirici A; Bogdan F
Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069
[TBL] [Abstract][Full Text] [Related]
28. Histological characteristics of basal cell carcinoma of the eyelid.
Paavilainen V; Aaltonen M; Tuominen J; Saari KM
Ophthalmic Res; 2007; 39(1):45-8. PubMed ID: 17164577
[TBL] [Abstract][Full Text] [Related]
29. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
[TBL] [Abstract][Full Text] [Related]
30. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
31. [Basal cell carcinoma of the nose].
Bonvallot T; Raulo Y; Zeller J; Faivre JM; Horn G; Baruch J
Ann Dermatol Venereol; 1993; 120(3):209-14. PubMed ID: 8239358
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of computer-assisted morphological and morphometrical analysis for detecting the recurrence tendency of basal cell carcinoma.
Cheretis C; Angelidou E; Dietrich F; Politi E; Kiaris H; Koutselini H
Med Sci Monit; 2008 May; 14(5):MT13-19. PubMed ID: 18443558
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors.
Safatle-Ribeiro AV; Ribeiro U; Corbett CE; Iriya K; Kobata CH; Sakai P; Yagi OK; Pinto PE; Zilberstein B; Gama-Rodrigues J
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):21-8. PubMed ID: 17206073
[TBL] [Abstract][Full Text] [Related]
34. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
35. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
Cornfield DB; Palazzo JP; Schwartz GF; Goonewardene SA; Kovatich AJ; Chervoneva I; Hyslop T; Schwarting R
Cancer; 2004 Jun; 100(11):2317-27. PubMed ID: 15160334
[TBL] [Abstract][Full Text] [Related]
36. Follow-up of basal cell carcinomas: an audit of current practice.
Mc Loone NM; Tolland J; Walsh M; Dolan OM
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):698-701. PubMed ID: 16836498
[TBL] [Abstract][Full Text] [Related]
37. Single fraction radiotherapy for small superficial carcinoma of the skin.
Chan S; Dhadda AS; Swindell R
Clin Oncol (R Coll Radiol); 2007 May; 19(4):256-9. PubMed ID: 17379488
[TBL] [Abstract][Full Text] [Related]
38. Recurrent morphean basal cell carcinoma of the skin. A clinico-histopathological study of 97 cases.
Anthouli-Anagnostopoulou F; Hatziolou E
Adv Clin Path; 2002 Jan; 6(1):17-24. PubMed ID: 17582944
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors.
Matsumoto M; Furihata M; Kurabayashi A; Ohtsuki Y
Oncol Rep; 2004 Nov; 12(5):1039-43. PubMed ID: 15492790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
